Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.05
1% from low
Exchange
OTC Link
OS
Borrow rate
524.16%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.4M | $15.8M | $14.8M | $17.7M | $3.5M | $29.2M | $471.0K | $255.0K |
| Cost of revenue | $1.1M | $2.6M | $3.6M | $5.0M | $7.9M | $14.3M | $15.2M | $2.4M |
| Gross profit | $5.3M | $13.2M | $11.3M | $12.8M | −$4.4M | $14.9M | −$2.1M | −$2.2M |
| Gross margin | 82.8% | 83.4% | 76.0% | 72.0% | -124.5% | 51.0% | -439.5% | -860.4% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$57.4K | −$6.5M | $4.7M | $2.4M | −$16.2M | −$2.1M | −$18.5M | −$20.1M |
| EBITDA | $4.1M | −$6.2M | $5.1M | $4.3M | −$14.5M | −$1.4M | −$20.0M | −$19.2M |
| Net income | −$54.1K | −$5.5M | $4.3M | $2.7M | −$15.0M | −$2.8M | −$30.1M | −$26.1M |
| Net margin | -0.9% | -34.8% | 29.2% | 15.3% | -426.7% | -9.4% | -6393.2% | -10226.7% |
| EPS (diluted) | -0.22 | -16.56 | 9.61 | 6.48 | -41.50 | -4.70 | -40.06 | -6.10 |
Annual figures · source: Financial Modeling Prep
ASSURE HLDGS CORP
No one on the platform currently holds IONM.
No tracked institution reports a position in IONM as of their last filing.
| Execution date | Ratio |
|---|---|
| 2024-07-09 | 1-for-18reverse |
| 2023-03-06 | 1-for-20reverse |
No one on the platform has traded IONM yet.
| $1990 |
| — |
| JWCAFJames E. Wagner Cultivation Corporation | $0.00 | +0.00% | $10942 | — |
| LGNDLigand Pharmaceuticals Incorporated | $315.23 | +0.38% | $6.3B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.0× sales vs its 614.7× historical median P/S.
Fair value ≈ $198.70 · price $0.00 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Fundamental analysis of $IONM (Assure Holdings Corp.) based on financial data and reported results. #IONM #Assure
View on StockTwits ↗$IONM let's do this come join me in a free discord link in my stoctwits Profile my bullish 🐂 peeps
View on StockTwits ↗$IONM $HIND more bad news a private offering with nothing left for retail investors 🧐🤷♂️
View on StockTwits ↗$IONM Rough ride for IONM. Delisted from Nasdaq, asset sale, DOJ settlement. Tough spot with limited markets. Might have potential if they can turn things around. Watching closely but skeptical. Could be a speculative play for risk-tolerant investors. superb article: https://beyondspx.com/article/assure-holdings-corp-ionm-pioneering-intraoperative-neuromonitoring-services-amidst-challenging-times
View on StockTwits ↗$IONM $HIND why should you make a offering after the announcement of a merger and all/most assets sold 🤔🤷🏻♂️
View on StockTwits ↗$IONM $HIND I’ll raise the red flag 🚩 again looks like copy of IONM going from 15$ to 1 cent in less than a year announced a merger sold everything for a couple of millions and end the cancelled the merger 🤔🤷♂️
View on StockTwits ↗$IONM Assure Holdings Corp. (NASDAQ:IONM) – Navigating the Evolving Intraoperative Neuromonitoring Landscape https://beyondspx.com/article/assure-holdings-corp-ionm-navigating-the-evolving-intraoperative-neuromonitoring-landscape
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.